News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
848,250 Results
Type
Article (86553)
Company Profile (702)
Press Release (760995)
Multimedia
Podcasts (132)
Webinars (14)
Section
Business (232713)
Career Advice (4128)
Deals (39727)
Drug Delivery (129)
Drug Development (90995)
Employer Resources (198)
FDA (18118)
Job Trends (17342)
News (396521)
Policy (39758)
Tag
Academia (3001)
Academic (2)
Accelerated approval (7)
Adcomms (30)
Allergies (96)
Alliances (56853)
ALS (107)
Alzheimer's disease (1513)
Antibody-drug conjugate (ADC) (166)
Approvals (18074)
Artificial intelligence (340)
Autoimmune disease (30)
Automation (17)
Bankruptcy (405)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (120)
Biotechnology (481)
Bladder cancer (88)
Brain cancer (33)
Breast cancer (324)
Cancer (2544)
Cardiovascular disease (213)
Career advice (3535)
Career pathing (34)
CAR-T (185)
Cell therapy (518)
Cervical cancer (22)
Clinical research (73563)
Collaboration (950)
Company closure (2)
Compensation (597)
Complete response letters (30)
COVID-19 (2872)
CRISPR (53)
C-suite (281)
Cystic fibrosis (110)
Data (2460)
Decentralized trials (2)
Denatured (46)
Depression (57)
Diabetes (308)
Diagnostics (6940)
Digital health (23)
Diversity (9)
Diversity, equity & inclusion (48)
Drug discovery (156)
Drug pricing (136)
Drug shortages (33)
Duchenne muscular dystrophy (109)
Earnings (97352)
Editorial (47)
Employer branding (25)
Employer resources (167)
Events (130441)
Executive appointments (804)
FDA (19598)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (855)
Gene editing (129)
Generative AI (36)
Gene therapy (385)
GLP-1 (870)
Government (5180)
Grass and pollen (6)
Guidances (174)
Healthcare (20894)
Huntington's disease (26)
IgA nephropathy (32)
Immunology and inflammation (158)
Indications (31)
Infectious disease (3037)
Inflammatory bowel disease (159)
Inflation Reduction Act (12)
Influenza (59)
Intellectual property (104)
Interviews (813)
IPO (17844)
IRA (51)
Job creations (5190)
Job search strategy (2861)
Kidney cancer (11)
Labor market (47)
Layoffs (569)
Leadership (24)
Legal (10118)
Liver cancer (82)
Lung cancer (356)
Lymphoma (169)
Machine learning (9)
Management (65)
Manufacturing (382)
MASH (87)
Medical device (14651)
Medtech (14656)
Mergers & acquisitions (22471)
Metabolic disorders (829)
Multiple sclerosis (92)
NASH (23)
Neurodegenerative disease (125)
Neuropsychiatric disorders (36)
Neuroscience (2159)
NextGen: Class of 2025 (7682)
Non-profit (5083)
Now hiring (42)
Obesity (442)
Opinion (276)
Ovarian cancer (85)
Pain (105)
Pancreatic cancer (91)
Parkinson's disease (170)
Partnered (25)
Patents (268)
Patient recruitment (124)
Peanut (51)
People (65380)
Pharmaceutical (143)
Pharmacy benefit managers (24)
Phase I (22708)
Phase II (31949)
Phase III (24052)
Pipeline (1520)
Policy (184)
Postmarket research (3552)
Preclinical (10255)
Press Release (72)
Prostate cancer (115)
Psychedelics (38)
Radiopharmaceuticals (271)
Rare diseases (446)
Real estate (7393)
Recruiting (75)
Regulatory (26859)
Reports (61)
Research institute (2659)
Resumes & cover letters (649)
Rett syndrome (7)
RNA editing (8)
RSV (50)
Schizophrenia (84)
Series A (148)
Series B (99)
Service/supplier (30)
Sickle cell disease (61)
Special edition (20)
Spinal muscular atrophy (166)
Sponsored (34)
Startups (4295)
State (2)
Stomach cancer (16)
Supply chain (76)
Tariffs (59)
The Weekly (84)
Vaccines (829)
Venture capitalists (45)
Weight loss (308)
Women's health (41)
Worklife (20)
Date
Today (127)
Last 7 days (955)
Last 30 days (3730)
Last 365 days (35502)
2025 (13789)
2024 (38139)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1271)
Alabama (62)
Alaska (7)
Arizona (271)
Arkansas (14)
Asia (50200)
Australia (8843)
California (6914)
Canada (2159)
China (589)
Colorado (299)
Connecticut (315)
Delaware (173)
Europe (115243)
Florida (1011)
Georgia (234)
Hawaii (1)
Idaho (64)
Illinois (656)
India (31)
Indiana (349)
Iowa (13)
Japan (183)
Kansas (114)
Kentucky (28)
Louisiana (16)
Maine (72)
Maryland (1009)
Massachusetts (5271)
Michigan (258)
Minnesota (441)
Mississippi (2)
Missouri (93)
Montana (31)
Nebraska (26)
Nevada (72)
New Hampshire (70)
New Jersey (1926)
New Mexico (31)
New York (1935)
North Carolina (1171)
North Dakota (10)
Northern California (2982)
Ohio (229)
Oklahoma (15)
Oregon (48)
Pennsylvania (1502)
Puerto Rico (14)
Rhode Island (36)
South America (1653)
South Carolina (28)
South Dakota (1)
Southern California (2556)
Tennessee (111)
Texas (1037)
United States (26274)
Utah (202)
Virginia (183)
Washington D.C. (73)
Washington State (632)
West Virginia (3)
Wisconsin (75)
There are 848,250 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) and have been approved by the Company’s Compensation Committee.
May 16, 2025
·
4 min read
Press Releases
NanoVibronix Announces Closing of $10 Million Public Offering of Preferred Stock and Warrants
May 16, 2025
·
6 min read
Press Releases
NervGen Pharma Grants Stock Options
May 16, 2025
·
1 min read
Press Releases
BioHarvest Sciences Reports First Quarter 2025 Financial Results
First Quarter Revenues Grew 47% to $7.9 Million, Exceeding Management Guidance
May 16, 2025
·
14 min read
Press Releases
Phio Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update
Clinical trial advances for INSTASYL siRNA lead product candidate PH-762 4th Cohort enrolling and treating patients in on-going clinical study
May 16, 2025
·
9 min read
Press Releases
Ellis Bio unveils SuperMethylTM Max kit for low-input DNA methylation workflows
New bisulfite chemistry delivers high-yield recovery and NGS compatibility for challenging epigenomic applications
May 16, 2025
·
1 min read
Layoff Tracker
Allogene Cuts 28% of Staff to Extend Runway, Focus on Clinical Programs
Follow along as
BioSpace
tracks job cuts and restructuring initiatives throughout 2025.
May 16, 2025
·
207 min read
·
BioSpace Editorial Staff
Press Releases
Mainz Biomed Announces Interim Read Out For Its eAArly DETECT 2 Clinical Study
May 16, 2025
·
5 min read
Press Releases
Vivex Biologics, Inc. Executive Chair Nominated for Ernst & Young LLP Entrepreneur of the Year® 2025 Florida Award
May 16, 2025
·
3 min read
Press Releases
PharmaTher Announces FDA Extends Review Period for Ketamine; New Approval Goal Date August 9, 2025
May 16, 2025
·
3 min read
1 of 84,825
Next
